FDA Limits Duchenne Gene Therapy, Elevidys, After Two Teens Die of Liver Failure
MONDAY, Nov. 17, 2025 The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after t